|
1
|
Siegall CB, FitzGerald DJ and Pastan I:
Selective killing of tumor cells using EGF or TGF
alpha-Pseudomonas exotoxin chimeric molecules. Semin Cancer
Biol. 1:345–350. 1990.PubMed/NCBI
|
|
2
|
Siegall CB, Xu YH, Chaudhary VK, Adhya S,
Fitzgerald D and Pastan I: Cytotoxic activities of a fusion protein
comprised of TGF alpha and Pseudomonas exotoxin. FASEB J.
3:2647–2652. 1989.PubMed/NCBI
|
|
3
|
Prestrelski SJ, Arakawa T, Wu CS, O’Neal
KD, Westcott KR and Narhi LO: Solution structure and dynamics of
epidermal growth factor and transforming growth factor alpha. J
Biol Chem. 267:319–322. 1992.PubMed/NCBI
|
|
4
|
Chiron MF, Fryling CM and FitzGerald D:
Furin-mediated cleavage of Pseudomonas exotoxin-derived
chimeric toxins. J Biol Chem. 272:31707–31711. 1997.PubMed/NCBI
|
|
5
|
Phillips PC, Levow C, Catterall M, Colvin
OM, Pastan I and Brem H: Transforming growth
factor-α-Pseudomonas exotoxin fusion protein (TGF-α-PE38)
treatment of subcutaneous and intracranial human glioma and
medulloblastoma xenografts in athymic mice. Cancer Res.
54:1008–1015. 1994.
|
|
6
|
Wright SE, Khaznadar R, Wang Z, et al:
Generation of MUC1-stimulated mononuclear cells using optimized
conditions. Scand J Immunol. 67:24–29. 2008.PubMed/NCBI
|
|
7
|
Wright SE, Rewers-Felkins KA, Quinlin IS,
et al: Adoptive immunotherapy of mucin1 expressing adenocarcinomas
with mucin1 stimulated human peripheral blood mononuclear cells.
Int J Mol Med. 9:401–404. 2002.PubMed/NCBI
|
|
8
|
Quinlin IS, Burnside JS, Dombrowski KE,
Phillips CA, Dolby N and Wright SE: Context of MUC1 epitope:
immunogenicity. Oncol Rep. 17:453–456. 2007.PubMed/NCBI
|
|
9
|
Wright SE, Kilinski L, Talib S, et al:
Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated
by native MUC1 mucin and a mucin peptide mutated at a glycosylation
site. J Immunother. 23:2–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wright SE, Rewers-Felkins KA, Quinlin IS,
et al: MHC-unrestricted lysis of MUC1-expressing cells by human
peripheral blood mononuclear cells. Immunol Invest. 37:215–225.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alajez NM, Schmielau J, Alter MD, Cascio M
and Finn OJ: Therapeutic potential of a tumor-specific,
MHC-unrestricted T-cell receptor expressed on effector cells of the
innate and the adaptive immune system through bone marrow
transduction and immune reconstitution. Blood. 105:4583–4589. 2005.
View Article : Google Scholar
|
|
12
|
Kanof ME and Smith PD: Preparation of
human mononuclear cell populations and subpopulations. Current
Protocols in Immunology. Coligan JE: John Wiley & Sons, Inc;
New York, NY: pp. 72009
|
|
13
|
Barnd DL, Lan MS, Metzgar RS and Finn OJ:
Specific, major histocompatibility complex-unrestricted recognition
of tumor-associated mucins by human cytotoxic T cells. Proc Natl
Acad Sci USA. 86:7159–7163. 1989. View Article : Google Scholar
|
|
14
|
Roehm NW, Rodgers GH, Hatfield SM and
Glasebrook AL: An improved colorimetric assay for cell
proliferation and viability utilizing the tetrazolium salt XTT. J
Immunol Methods. 142:257–265. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jost LM, Kirkwood JM and Whiteside TL:
Improved short- and long-term XTT-based colorimetric cellular
cytotoxicity assay for melanoma and other tumor cells. J Immunol
Methods. 147:153–165. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Altman SA, Randers L and Rao G: Comparison
of Trypan blue dye exclusion and fluorometric assays for mammalian
cell viability determinations. Biotechnol Prog. 9:671–674. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bode AM, Ma W-Y, Surh Y-J and Dong Z:
Inhibition of epidermal growth factor-induced cell transformation
and activator protein 1 activation by [6]-gingerol. Cancer Res.
61:850–853. 2001.
|
|
18
|
Vennstrom L, Bysell C, Bjorkelund H,
Lundqvist H and Andersson K: Real-time viability assay based on
51Cr retention in adherent cells. Biotechniques. 44:237–240. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu MH, Liebowitz DN, Smith SL, Williams SF
and Dolan ME: Efficient expression of foreign genes in human CD34+
hematopoietic precursor cells using electroporation. Gene Therapy.
8:3842001.
|
|
20
|
Petty AP, Wright SE, Rewers-Felkins KA,
Yenderrozos MA, Vorderstrasse BA and Lindsey JS: Targeting
migration inducting gene-7 inhibits carcinoma cell invasion, early
primary tumor growth, and stimulates monocyte oncolytic activity.
Mol Cancer Ther. 8:2412–2423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ross AA, Cooper BW, Lazarus HM, et al:
Detection and viability of tumor cells in peripheral blood stem
cell collections from breast cancer patients using
immunocytochemical and clonogenic assay techniques. Blood.
82:2605–2610. 1993.PubMed/NCBI
|
|
22
|
Rill DR, Santana VM, Roberts WM, et al:
Direct demonstration that autologous bone marrow transplantation
for solid tumors can return a multiplicity of tumorigenic cells.
Blood. 84:380–383. 1994.PubMed/NCBI
|
|
23
|
Braun S, Vogl FD, Naume B, et al: A pooled
analysis of bone marrow micrometastasis in breast cancer. N Engl J
Med. 353:793–802. 2005. View Article : Google Scholar : PubMed/NCBI
|
